文献速递创伤与烧伤复苏、休克与脓毒症心脑血管急症

院前气管插管的创伤性脑损伤患者继发性损伤的发生率与结局:一项回顾性队列研究

Prevalence of secondary insults and outcomes of patients with traumatic brain injury intubated in the prehospital setting: a retrospective cohort study.
PubMed 文献 · Emerg Med J · 2023-01-05
一句话结论院前经快速序贯插管的创伤性脑损伤患者中,任何继发性损伤与28天死亡率升高相关(34.9% vs 14.7%), prolonged hypoxia 是死亡的独立预测因子(aOR 4.86)。

该回顾性队列研究纳入2017年1月1日至2020年12月31日期间澳大利亚昆士兰东南部某城市陆路院前急救服务中接受快速序贯插管的成人创伤性脑损伤患者277例。患者按是否发生任何继发性损伤分为两组,继发性损伤定义为持续≥5分钟的长时间低血压、长时间低氧血症和过度通气。28天死亡率为26%,发生任何继发性损伤者死亡率高于未发生者(34.9% vs 14.7%,p<0.001)。多因素logistic回归显示,长时间低氧血症是死亡的独立预测因子(aOR 4.86,95%CI 1.65-15.61),而长时间低血压(aOR 1.45,95%CI 0.5-4.25)和到院时呼气末二氧化碳<30 mm Hg(aOR 1.28,95%CI 0.5-3.21)无独立预测作用。作者认为创伤性脑损伤中长时间低氧血症与死亡的相关性可能比既往认识更重要,早期纠正可能改善结局,旁观者干预在预防早期低氧性损伤中可能有更大作用。

要点

  • 院前插管的成人创伤性脑损伤患者中,发生任何继发性损伤者28天死亡率为34.9%,未发生者为14.7%(p<0.001)。
  • 长时间低氧血症是死亡的独立预测因子(aOR 4.86,95%CI 1.65-15.61),长时间低血压(aOR 1.45,95%CI 0.5-4.25)和到院时呼气末二氧化碳<30 mm Hg(aOR 1.28,95%CI 0.5-3.21)未显示独立预测作用。
  • 大多数长时间低血压和长时间低氧血症发作在首次现场接触患者时即被检出。
  • 继发性损伤定义为持续≥5分钟的长时间低血压、长时间低氧血症和过度通气,在院前早期阶段常见。
  • 作者认为创伤性脑损伤中长时间低氧血症与死亡的相关性可能比既往认识更重要,早期纠正可能改善结局,旁观者干预在预防早期低氧性损伤中可能有更大作用。

适用人群与场景

  • 2017年1月1日至2020年12月31日期间,澳大利亚昆士兰东南部某城市陆路院前急救服务中接受快速序贯插管的成人创伤性脑损伤患者。

诊断标准与关键阈值

  • 继发性损伤定义为持续≥5分钟的长时间低血压、长时间低氧血症和过度通气。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入277例患者;中位头部简明损伤定级为4(IQR 3-5),中位损伤严重度评分为26(IQR 17-34)。
  • 28天死亡率为26%;发生任何继发性损伤者死亡率34.9%,未发生者为14.7%(p<0.001)。
  • 长时间低氧血症是死亡的独立预测因子(aOR 4.86,95%CI 1.65-15.61);长时间低血压(aOR 1.45,95%CI 0.5-4.25)和到院时呼气末二氧化碳<30 mm Hg(aOR 1.28,95%CI 0.5-3.21)无独立预测作用。
  • 大多数长时间低血压和长时间低氧血症发作在首次现场接触患者时即被检出。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为创伤性脑损伤中长时间低氧血症与死亡的相关性可能比既往认识更重要,早期纠正可能改善结局。
  • 作者认为旁观者干预在预防创伤性脑损伤早期低氧性损伤中可能有更大作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Prehospital neuroprotective strategies aim to prevent secondary insults (SIs) in traumatic brain injury (TBI). This includes haemodynamic optimisation in addition to oxygenation and ventilation targets achieved through rapid sequence intubation (RSI).The primary aim was to report the incidence and prevalence of SIs (prolonged hypotension, prolonged hypoxia and hyperventilation) and outcomes of patients with TBI who were intubated in the prehospital setting.

METHODS: A retrospective cohort study of adult patients with TBI who underwent RSI by a metropolitan road-based service in South-East Queensland, Australia between 1 January 2017 and 31 December 2020. Patients were divided into two cohorts based on the presence or absence of any SI sustained. Prolonged SIs were defined as occurring for ≥5 min. The association between SIs and mortality was examined in multivariable logistic regression and reported with adjusted ORs (aORs) and 95% CIs.

RESULTS: 277 patients were included for analysis. Median 'Head' Abbreviated Injury Scale and Injury Severity Score were 4 (IQR: 3-5) and 26 (IQR: 17-34), respectively. Most episodes of prolonged hypotension and prolonged hypoxia were detected with the first patient contact on scene. Overall, 28-day mortality was 26%. Patients who sustained any SI had a higher mortality than those sustaining no SI (34.9% vs 14.7%, p<0.001). Prolonged hypoxia was an independent predictor of mortality (aOR 4.86 (95% CI 1.65 to 15.61)) but not prolonged hypotension (aOR 1.45 (95% CI 0.5 to 4.25)) or an end-tidal carbon dioxide <30 mm Hg on hospital arrival (aOR 1.28 (95% CI 0.5 to 3.21)).

CONCLUSION: SIs were common in the early phase of prehospital care. The association of prolonged hypoxia and mortality in TBI is potentially more significant than previously recognised, and if corrected early, may improve outcomes. There may be a greater role for bystander intervention in prevention of early hypoxic insult in TBI.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Butterfield M, Bodnar D, Williamson F, et al. Prevalence of secondary insults and outcomes of patients with traumatic brain injury intubated in the prehospital setting: a retrospective cohort study. Emerg Med J. 2023. PMID: 36604161. doi:10.1136/emermed-2022-212513

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。